Dexlofexidine or levlofexidine or lofexidine
- Level
- Commodity
- Parent
- 51392200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51392209This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5SPW497X0Z, chemically known as (-)-(r)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline. but generally known as levlofexidine, which bears US NIH Compound Identifier 3038503. European Medicines Agency schedules Levlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08461MIG. The term LEVLOFEXIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). LEVLOFEXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl.
Same parent
Under 51392200 · 30Activities that produce or sell this
KBLI · 8Inherited from family 51390000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.